
Saudi Standards, Metrology and Quality Organization (SASO) issued an urgent technical notice on May 9, 2026, mandating recertification of all Smart Orthotics products—both currently marketed and newly registered—against the updated IEC 60601-2-77:2026 standard by June 30, 2026. This development directly affects medical device exporters, regulatory compliance teams, and healthcare distribution stakeholders operating in or targeting the Middle East market.
On May 9, 2026, SASO published an urgent technical notification requiring all Smart Orthotics products sold or seeking registration in Saudi Arabia to complete conformity assessment under IEC 60601-2-77:2026 no later than June 30, 2026. The revised standard places heightened emphasis on electromagnetic compatibility (EMC) performance and human-machine interaction safety verification. The deadline applies uniformly to existing and new product registrations and is enforceable for customs clearance, distributor onboarding, and hospital procurement processes.
Exporters supplying Smart Orthotics to Saudi Arabia face immediate compliance pressure. Failure to meet the June 30, 2026 deadline may result in shipment rejection at port, withdrawal from authorized distributor catalogs, and inability to fulfill active supply contracts with hospitals or government tenders.
Manufacturers—especially those based in China producing Smart Orthotics for global brands—must revalidate design and production controls against the new EMC and usability requirements. Revised test reports will be required for each model variant, potentially triggering engineering reviews, firmware updates, or shielding modifications.
Regional distributors and importers holding existing SASO Product Registration Certificates must submit updated conformity documentation before the deadline to maintain listing eligibility. Shelf-ready inventory without valid IEC 60601-2-77:2026 certification may be blocked from further sales or subject to recall coordination with local authorities.
Testing laboratories and Notified Bodies accredited for IEC 60601-2-77 are experiencing elevated demand for expedited test cycles. Capacity constraints may delay turnaround times; service providers must verify their accreditation scope explicitly covers the 2026 edition and its annexes related to wireless coexistence and touch-interface safety.
While the May 9 notice establishes the deadline and scope, SASO has not yet published implementation guidance on transitional provisions, grandfathering of legacy certificates, or accepted pathways for partial retesting. Stakeholders should track SASO’s official portal and authorized conformity assessment body bulletins for updates through June 2026.
Companies should triage their Smart Orthotics portfolio by sales volume in Saudi Arabia, contractual delivery timelines, and inclusion in upcoming public health procurement cycles. Models already cleared under IEC 60601-2-77:2015 may require full retesting—not just gap analysis—given the expanded EMC test severity and new human-factors evaluation criteria.
The notice functions as a binding regulatory requirement—not a recommendation. However, enforcement timing may vary across customs points and procurement agencies. Companies should treat the June 30 deadline as non-negotiable for new registrations and assume zero tolerance for unverified shipments arriving after July 1, 2026.
Recertification requires cross-functional alignment: engineering teams must confirm hardware/firmware readiness; quality units must update test protocols and retain evidence; regulatory staff must prepare submission packages aligned with SASO’s latest technical file templates. Early engagement with testing labs—including scheduling slots—is advisable given anticipated demand surges.
Observably, this SASO notice signals tightening harmonization with the latest IEC 60601-2-77 revision—not merely administrative updating. The explicit focus on EMC robustness and interactive safety reflects growing regional scrutiny of connected medical devices, especially those incorporating Bluetooth, capacitive sensors, or adaptive control logic. Analysis shows that while the deadline is short, it aligns with broader Gulf Cooperation Council (GCC) trends toward adopting post-2020 IEC revisions without extended transition periods. From an industry perspective, this is less a one-off compliance event and more a leading indicator of accelerated regulatory convergence across GCC markets—particularly where wireless-enabled therapeutic devices are concerned.
Consequently, this notice is best understood not as an isolated deadline but as a procedural checkpoint reinforcing that product lifecycle management for export-oriented medical device firms must now embed continuous standards monitoring—not just initial certification—as a core operational discipline.
Conclusion: The SASO directive underscores that regulatory agility—not just technical compliance—is becoming decisive for market access in the GCC. For Smart Orthotics stakeholders, the June 30, 2026 deadline represents a concrete inflection point where proactive alignment with evolving international safety benchmarks directly determines commercial continuity. It is more accurately interpreted as a time-bound enforcement milestone within an ongoing regulatory maturation process—not a standalone policy shift.
Source Attribution:
- Saudi Standards, Metrology and Quality Organization (SASO), Technical Notification dated May 9, 2026
- IEC 60601-2-77:2026 Edition, International Electrotechnical Commission
Note: Implementation details—including acceptance of third-country test reports, transitional arrangements, and SASO-specific interpretation of Annexes—are pending further official clarification and remain under observation.
Recommended News
The VitalSync Intelligence Brief
Receive daily deep-dives into MedTech innovations and regulatory shifts.